12 results · 22ms · Sources: EU EUDAMED, US FDA

Get notified when this changes

We'll email you when new records match this search — new devices, new clearances, certificate changes, or withdrawals.

Medi-Direct TENS Pen

FDA 510(k)
FDA Class 2 ·Neurology

HERCULITE ULTRA

FDA 510(k)
FDA Class 2 ·Dental

SYNGO RT THERAPIST CONNECT WORKSPACE, V4.2

FDA 510(k)
FDA Class 2 ·Radiology

ROUND FILTER POLYPROVPYLENE

FDA Adverse Event
Malfunction ·SPS MEDICAL SUPPLY CORP·Product code FRG·June 25, 2013

SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE

FDA Adverse Event
Injury ·BAXTER HEALTHCARE·Product code KDJ·June 21, 2013

OT PING METER

FDA Adverse Event
Malfunction ·LIFESCAN INC.·Product code NBW·July 28, 2011

INTELECT ADVANCED COMBO MONOCHROME

FDA Adverse Event
Malfunction ·CHATTANOOGA GROUP·Product code IMG·September 25, 2008

MULTI-SIDEPORT DUAL CHECK VALVE CATHETER INFUSION SET

FDA Adverse Event
Injury ·COOK INC·Product code KRA·April 27, 2022

MULTI-SIDEPORT DUAL CHECK VALVE CATHETER INFUSION SET

FDA Adverse Event
Malfunction ·COOK INC·Product code KRA·April 11, 2022

MULTI-SIDEPORT DUAL CHECK VALVE CATHETER INFUSION SET

FDA Adverse Event
Malfunction ·COOK INC·Product code KRA·August 19, 2022

BENDING PLIERS FOR 3.5MM CLAVICLE PLATES/227MM LENGTH

FDA Adverse Event
Malfunction ·SYNTHES TUTTLINGEN·Product code HXP·July 16, 2015

Boston Scientific COGNIS CRT-D, Cardiac Resynchronization Therapy Defibrillator, models N118, N119. The following models are not available in the US: models N106, N107, P106, P107. Sterilized using ethylene oxide. Product Usage: Boston Scientific cardiac resynchronization therapy defibrillators (CRT-Ds) are indicated for patients with moderate to severe heart failure who remain symptomatic despite stable, optimal heart failure drug therapy and have left ventricular dysfunction and QRS duration > or equal to 120 ms. This family of pulse generators provide a variety of therapies including: -Ventricular tachyarrhythmia therapy, which is used to treat rhythms associated with sudden cardiac death such as VT and VF; -Cardiac Resynchronization Therapy (CRT), which treats heart failure by resynchronizing ventricular contractions through biventricular electrical stimulation; -Bradycardia pacing, including adaptive rate pacing, to detect and treat bradyarrhythmias and to provide cardiac rate support after defibrillation therapy.

FDA Enforcement
Class II ·Terminated·Boston Scientific CRM Corp·October 29, 2014